Detailed information for compound 1433884

Basic information

Technical information
  • TDR Targets ID: 1433884
  • Name: methyl 3-(2-chloro-6-fluorophenyl)-5-(1-dimet hylamino-4-ethoxy-3,4-dioxobut-1-en-2-yl)-1,2 -oxazole-4-carboxylate
  • MW: 424.807 | Formula: C19H18ClFN2O6
  • H donors: 0 H acceptors: 4 LogP: 3.09 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCOC(=O)C(=O)/C(=C\N(C)C)/c1onc(c1C(=O)OC)c1c(F)cccc1Cl
  • InChi: 1S/C19H18ClFN2O6/c1-5-28-19(26)16(24)10(9-23(2)3)17-14(18(25)27-4)15(22-29-17)13-11(20)7-6-8-12(13)21/h6-9H,5H2,1-4H3/b10-9+
  • InChiKey: QDHWUSVTPZHUDS-MDZDMXLPSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • methyl 3-(2-chloro-6-fluorophenyl)-5-[(Z)-1-dimethylamino-4-ethoxy-3,4-dioxobut-1-en-2-yl]-1,2-oxazole-4-carboxylate
  • methyl 3-(2-chloro-6-fluoro-phenyl)-5-[1-(dimethylaminomethylene)-3-ethoxy-2,3-dioxo-propyl]isoxazole-4-carboxylate
  • methyl 3-(2-chloro-6-fluoro-phenyl)-5-[(1Z)-1-(dimethylaminomethylene)-3-ethoxy-2,3-dioxo-propyl]isoxazole-4-carboxylate
  • 3-(2-chloro-6-fluorophenyl)-5-[(1Z)-1-(dimethylaminomethylene)-3-ethoxy-2,3-dioxopropyl]-4-isoxazolecarboxylic acid methyl ester
  • 3-(2-chloro-6-fluorophenyl)-5-[1-(dimethylaminomethylene)-3-ethoxy-2,3-dioxopropyl]-4-isoxazolecarboxylic acid methyl ester
  • 3-(2-chloro-6-fluoro-phenyl)-5-[(Z)-2-dimethylamino-1-(2-ethoxy-2-keto-acetyl)vinyl]isoxazole-4-carboxylic acid methyl ester
  • 3-(2-chloro-6-fluoro-phenyl)-5-[2-dimethylamino-1-(2-ethoxy-2-keto-acetyl)vinyl]isoxazole-4-carboxylic acid methyl ester
  • methyl 3-(2-chloro-6-fluoro-phenyl)-5-[(Z)-1-dimethylamino-4-ethoxy-3,4-dioxo-but-1-en-2-yl]-1,2-oxazole-4-carboxylate
  • methyl 3-(2-chloro-6-fluoro-phenyl)-5-(1-dimethylamino-4-ethoxy-3,4-dioxo-but-1-en-2-yl)-1,2-oxazole-4-carboxylate
  • SMR000170031
  • methyl 3-(2-chloro-6-fluorophenyl)-5-[2-(dimethylamino)-1-(2-ethoxy-2-oxoacetyl)vinyl]-4-isoxazolecarboxylate
  • 6L-044
  • MLS000325933

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens hydroxyprostaglandin dehydrogenase 15-(NAD) Starlite/ChEMBL No references
Homo sapiens ataxin 2 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Plasmodium falciparum steroid dehydrogenase, putative hydroxyprostaglandin dehydrogenase 15-(NAD) 266 aa 216 aa 22.2 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) hypothetical protein 0.0101 0.1246 0.1246
Brugia malayi Carboxylesterase family protein 0.0101 0.1246 0.1246
Echinococcus multilocularis carboxylesterase 5A 0.06 1 1
Brugia malayi Carboxylesterase family protein 0.0101 0.1246 0.1246
Loa Loa (eye worm) carboxylesterase 0.0101 0.1246 0.1246
Echinococcus granulosus acetylcholinesterase 0.06 1 1
Loa Loa (eye worm) hypothetical protein 0.0101 0.1246 0.1246
Toxoplasma gondii LsmAD domain-containing protein 0.003 0 0.5
Echinococcus granulosus acetylcholinesterase 0.06 1 1
Loa Loa (eye worm) carboxylesterase 0.06 1 1
Loa Loa (eye worm) hypothetical protein 0.06 1 1
Loa Loa (eye worm) hypothetical protein 0.0101 0.1246 0.1246
Onchocerca volvulus 0.0101 0.1246 0.5
Plasmodium vivax ataxin-2 like protein, putative 0.003 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0101 0.1246 0.1246
Echinococcus multilocularis acetylcholinesterase 0.06 1 1
Onchocerca volvulus 0.0101 0.1246 0.5
Loa Loa (eye worm) acetylcholinesterase 1 0.06 1 1
Mycobacterium tuberculosis POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) 0.0101 0.1246 0.5
Plasmodium falciparum ataxin-2 like protein, putative 0.003 0 0.5
Mycobacterium tuberculosis POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) 0.0101 0.1246 0.5
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.06 1 1
Trypanosoma brucei PAB1-binding protein , putative 0.003 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0101 0.1246 0.1246
Echinococcus granulosus carboxylesterase 5A 0.06 1 1
Echinococcus multilocularis acetylcholinesterase 0.06 1 1
Trichomonas vaginalis spcc417.12 protein, putative 0.0101 0.1246 0.5
Trypanosoma cruzi PAB1-binding protein , putative 0.003 0 0.5
Onchocerca volvulus 0.0101 0.1246 0.5
Trypanosoma cruzi PAB1-binding protein , putative 0.003 0 0.5
Loa Loa (eye worm) carboxylesterase 0.0101 0.1246 0.1246
Onchocerca volvulus 0.0101 0.1246 0.5
Mycobacterium tuberculosis Carboxylesterase LipT 0.0101 0.1246 0.5
Brugia malayi Carboxylesterase family protein 0.0101 0.1246 0.1246
Brugia malayi hypothetical protein 0.0101 0.1246 0.1246
Loa Loa (eye worm) hypothetical protein 0.06 1 1
Plasmodium falciparum ataxin-2 like protein, putative 0.003 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0101 0.1246 0.1246
Trichomonas vaginalis carboxylesterase domain containing protein, putative 0.0101 0.1246 0.5
Brugia malayi Carboxylesterase family protein 0.06 1 1
Leishmania major hypothetical protein, conserved 0.003 0 0.5
Brugia malayi Carboxylesterase family protein 0.0101 0.1246 0.1246
Loa Loa (eye worm) hypothetical protein 0.0101 0.1246 0.1246
Mycobacterium ulcerans carboxylesterase, LipT 0.0101 0.1246 0.5
Onchocerca volvulus 0.0101 0.1246 0.5

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 1.8526 uM PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] ChEMBL. No reference
Potency (functional) = 10 um PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))] ChEMBL. No reference
Potency (functional) 10 uM PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 28.1838 uM PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] ChEMBL. No reference
Potency (functional) = 31.6228 um PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium. (Class of assay: confirmatory) [Related pubchem assays: 901 ] ChEMBL. No reference
Potency (functional) 89.1251 uM PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] ChEMBL. No reference
Potency (functional) 100 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Plasmodium falciparum ChEMBL23

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.